Introducing Anti-sLea/CA19-9 Antibody (5B1): A Powerful Tool for Biotech Research
As a leading biotech company, we are proud to offer our latest product, Anti-sLea/CA19-9 Antibody (5B1), to the scientific community. This highly specific antibody is designed to target and detect the sLea/CA19-9 antigen, making it an essential tool for a wide range of research applications.
Biological Function:
Anti-sLea/CA19-9 Antibody (5B1) is a monoclonal antibody that specifically binds to the sLea/CA19-9 antigen, a carbohydrate antigen present on the surface of various cancer cells. This antigen is known to be overexpressed in several types of cancer, including pancreatic, colorectal, and gastric cancer, making it a valuable biomarker for cancer detection and diagnosis.
Main Applications:
Anti-sLea/CA19-9 Antibody (5B1) has a wide range of applications in biotech research. Its main use is in cancer research, where it can be used to detect the presence of sLea/CA19-9 antigen in cancer cells. This can aid in the development of targeted therapies and personalized treatment plans for cancer patients. Additionally, this antibody can also be used in diagnostic tests for the early detection of cancer.
Experimental Use Cases:
Anti-sLea/CA19-9 Antibody (5B1) has been extensively tested in various experimental settings, and has shown excellent results in detecting the sLea/CA19-9 antigen. In one study, this antibody was used to successfully detect the antigen in tissue samples from pancreatic cancer patients, showing its potential as a diagnostic tool. In another study, it was used to target and destroy cancer cells in vitro, demonstrating its potential as a therapeutic agent.
Our Anti-sLea/CA19-9 Antibody (5B1) is a highly specific and sensitive tool for detecting the sLea/CA19-9 antigen in cancer cells. With its advanced technology and proven results, it is a valuable addition to any biotech research project focused on cancer.
Why Choose Anti-sLea/CA19-9 Antibody (5B1)?
Highly Specific and Sensitive:
Anti-sLea/CA19-9 Antibody (5B1) is specifically designed to target and detect the sLea/CA19-9 antigen, making it a highly specific and sensitive tool for cancer research.
Proven Results:
Extensive testing has shown that our antibody has excellent results in detecting the sLea/CA19-9 antigen, making it a reliable choice for biotech research.
Multiple Applications:
From cancer detection to therapeutic development, Anti-sLea/CA19-9 Antibody (5B1) has a wide range of applications in biotech research.
Trusted by Scientists:
Our antibody has been used in numerous experimental studies and has been praised for its accuracy and reliability by scientists in the field.
In conclusion, Anti-sLea/CA19-9 Antibody (5B1) is a powerful tool for biotech research, with its ability to target and detect the sLea/CA19-9 antigen. Its proven results and multiple applications make it a valuable addition to any cancer research project. Trust in our advanced technology and choose Anti-sLea/CA19-9 Antibody (5B1) for your next biotech experiment.
There are no reviews yet.